![In-Gyu Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
In-Gyu Lee
Direttore/Membro del Consiglio presso NOVMETAPHARMA CO., LTD.
Profilo
In-Gyu Lee is currently a Director at NovMetaPharma Co., Ltd.
and NovMetaHealth Co. Ltd.
He is also a Professor at Kyungpook National University, a position he has held since 2005.
He received his undergraduate, graduate, and doctorate degrees from Kyungpook National University.
Posizioni attive di In-Gyu Lee
Società | Posizione | Inizio |
---|---|---|
NOVMETAPHARMA CO., LTD. | Direttore/Membro del Consiglio | 13/12/2017 |
Kyungpook National University | Corporate Officer/Principal | 01/04/2005 |
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Direttore/Membro del Consiglio | - |
Formazione di In-Gyu Lee
Kyungpook National University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Borsa valori
- Insiders
- In-Gyu Lee